Skip to main content

Table 2 Incidence Rate of Neoplasia Onset, mortality and Comparison of Cumulative Incidence According to Lipid Levels

From: Association between plasma lipid levels during acute coronary syndrome and long-term malignancy risk. The ABC-4* study on heart disease

Variable

Person-years

Incidence rate/1000 person-years

Mantel-Haenszel estimates of rate ratio

Percent relative effect (%)

Pepe Mori cumulative incidence comparison

RR

X2

p value

X2

p value

Neoplasia onset after ACS (n = 99)

5544

       

Total cholesterol

 ≤ Median

23

0.54

8.8

0.003

85

7.4

0.006

 > Median

13

LDL cholesterol

 ≤ Median

23

0.58

7.1

0.007

72

4.6

0.03

 > Median

13

HDL cholesterol

 ≤ Median

17

1.10

0.2

0.63

−9

0.2

0.63

 > Median

19

Triglycerides

  ≤ median

20

0.75

2.0

0.16

33

2.5

0.11

  > median

15

Neoplasia-related death after ACS (n = 75)

5877

       

Total cholesterol

 ≤ Median

18

0.43

12.1

0.0005

133

10.7

0.001

 > Median

8

LDL cholesterol

 ≤ Median

18

0.45

11.4

0.0007

122

7.8

0.005

 > Median

8

HDL cholesterol

 ≤ Median

11

1.33

1.6

0.8

−25

0.5

0.47

 > Median

15

Triglycerides

 ≤ Median

15

0.68

2.7

0.09

47

1.6

0.20

 > Median

11

  1. ACS Acute coronary syndrome, HDL High-density lipoproteins, LDL Low-density lipoproteins